Abstract
The prostate is the largest gland annexed to the male reproductive system and is made up of a glandular and stromal component. The former, as described by McNeal, can be subdivided into three zones: central, transition and peripheral. The nonglandular part consists of the periprostatic sphincter, the anterior connective tissue and the prostatic capsule.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn 21:167–178
Nickel JC, Weidner W (2000) Chronic prostatitis: current concepts and antimicrobial therapy. Infect Urol 13:22–28
Pavone Macaluso M, Di Trapani D, Pavone C (1991) Prostatitis, prostatosis and prostalgia. Psychogenic or somatic disease? Scand J Urol Nephrol 138:77–82
Roberts RO, Jacobson DJ, Girman C et al (2002) Prevalence of prostatitis like symptoms in a community based cohort of older men. J Urol 168:2467–2471
Roberts RO, Lieber NM, Bostwick DG et al (1997) A review of clinical and pathological prostatitis syndromes. Urology 49:809–821
AUA Practice Guidelines Committee (2003) AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530–547
Girmar GJ, Jacobsen SJ, Tsukamoto T et al (1998) Health related quality of life associated with lower urinary tract symptom in four countries. Urology 51:428–436
Jacobsen SJ, Girman CJ, Guess HA et al (1995) New diagnostic and treatment guidelines for benign prostatic hyperplasia. Arch Intern Med 155:477–481
Mebust WK, Holtgrewe HL, Cockett ATK (1989) Transurethral prostatectomy: immediate and postoperative complication. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 41:243–247
Walsh PC, Retik AB et al (1998) Campbell’s urology, 7th ed. WB Saunders Co., Philadelphia
Abbas F, Scardino PT (1997) The natural history of clinical prostate carcinoma. Cancer 80:827–833
American Urological Association (AUA) (2000) Prostate specific antigen (PSA) best practice policy. Oncology 14:267–280
Bil Axelson A, Holmberg L, Ruutu M et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977–1984
Gleason DF (1997) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, pp 171–198
Mundy GR (1997) Mechanism of bone metastases. Cancer 80:1546–1556
Scardino PT (1989) Early detection of prostate cancer. Urol Clin North Am 16:635–655
Sooriakumaran P, Khaksar SJ, Shah J (2006) Management of prostate cancer. Part 2: localized and locally advanced disease. Expert Rev Anticancer Ther 6:595–603
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag
About this chapter
Cite this chapter
Zani, D., Simeone, C., Cunico, S.C. (2009). Clinical Approach to Prostate Disease. In: Grazioli, L., Olivetti, L. (eds) Imaging of Urogenital Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-1344-5_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-1344-5_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1343-8
Online ISBN: 978-88-470-1344-5
eBook Packages: MedicineMedicine (R0)